Cargando…

Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents

Producing human mesenchymal stromal cells (MSCs) for clinical use requires adherence to current good manufacturing practice (cGMP) standards. This is necessary for ensuring standardization and reproducibility through the manufacturing process, but also, for product quality and safety. However, the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanz-Nogués, Clara, O'Brien, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934414/ https://www.ncbi.nlm.nih.gov/pubmed/36824657 http://dx.doi.org/10.1016/j.bbiosy.2021.100018

Ejemplares similares

When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease
por: Calcat-i-Cervera, Sandra, et al.
Publicado: (2021)

Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review
por: Sensebé, Luc, et al.
Publicado: (2013)

Safety Profile of Good Manufacturing Practice Manufactured Interferon γ‐Primed Mesenchymal Stem/Stromal Cells for Clinical Trials
por: Guess, Adam J., et al.
Publicado: (2017)

Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production
por: Viganò, Mariele, et al.
Publicado: (2018)

Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice
por: Gándara, Carolina, et al.
Publicado: (2018)

Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality
por: Skovronova, Renata, et al.
Publicado: (2023)

Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
por: Castiglia, Sara, et al.
Publicado: (2014)

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody
por: Liew, A., et al.
Publicado: (2018)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

Scaffold-based delivery of mesenchymal stromal cells to diabetic wounds
por: Du, Shanshan, et al.
Publicado: (2022)

Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments
por: Bowles-Welch, Annie C., et al.
Publicado: (2023)

A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions
por: Canosa, Stefano, et al.
Publicado: (2022)

Food and Drink - Good Manufacturing Practice
por: Manning, Louise
Publicado: (2018)

Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach
por: Calcat-i-Cervera, Sandra, et al.
Publicado: (2023)

Human Synovial Mesenchymal Stem Cells Good Manufacturing Practices for Articular Cartilage Regeneration
por: Fernandes, Tiago Lazzaretti, et al.
Publicado: (2018)

Current therapeutic agents and anesthetic considerations for diabetes mellitus
por: Kang, Hyoseok
Publicado: (2012)

Knowledge, Perceptions and Concerns of Diabetes-Associated Complications among Individuals Living with Type 1 and Type 2 Diabetes Mellitus
por: Sanz-Nogués, Clara, et al.
Publicado: (2020)

Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
por: Fernández-Santos, Maria Eugenia, et al.
Publicado: (2022)

Porcine lung mesenchymal stromal cells possess differentiation and immunoregulatory properties
por: Khatri, Mahesh, et al.
Publicado: (2015)

Good manufacturing practices for pharmaceuticals : a plan for total quality control
por: Willig, Sidney H., 1919-
Publicado: (1997)

Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis
por: Cigognini, Daniela, et al.
Publicado: (2016)

Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization
por: Mizukami, Amanda, et al.
Publicado: (2018)

Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
por: Liew, Aaron, et al.
Publicado: (2012)

Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production
por: Camilleri, Emily T., et al.
Publicado: (2016)

Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019)

Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal.
por: Velagaleti, Ranga, et al.
Publicado: (2002)

The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices
por: Fabio, Petrelli, et al.
Publicado: (2019)

Isolation and characterization of chicken lung mesenchymal stromal cells and their susceptibility to avian influenza virus
por: Khatri, Mahesh, et al.
Publicado: (2010)

Good manufacturing practices for medicinal products for human use
por: Gouveia, Bruno G., et al.
Publicado: (2015)

Translating Research into Clinical Scale Manufacturing of Mesenchymal Stromal Cells
por: Bieback, Karen, et al.
Publicado: (2011)

Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice‐Manufactured Human Induced Pluripotent Stem Cell Line
por: Zhu, Jie, et al.
Publicado: (2017)

Biological Considerations in Scaling Up Therapeutic Cell Manufacturing
por: Cherian, Darshana S., et al.
Publicado: (2020)

Practical Considerations for Translating Mesenchymal Stromal Cell-Derived Extracellular Vesicles from Bench to Bed
por: Lui, Pauline Po Yee, et al.
Publicado: (2022)

Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
por: Pham, Phuc Van, et al.
Publicado: (2014)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
por: Mareschi, Katia, et al.
Publicado: (2022)

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly
por: Sypecka, Monika, et al.
Publicado: (2022)

Considering Cell Therapy Product “Good Manufacturing Practice” Status
por: Bedford, Patrick, et al.
Publicado: (2018)

Exosomes in clinical trial and their production in compliance with good manufacturing practice
por: Chen, Yu-Shuan, et al.
Publicado: (2019)

Understanding the impact of bioactive coating materials for human mesenchymal stromal cells and implications for manufacturing
por: Silva Couto, Pedro, et al.
Publicado: (2023)

Validation of analytical methods in compliance with good manufacturing practice: a practical approach
por: Rustichelli, Deborah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2jvl2bv2i0nfon8mgkne4edp3u